Latest return on equity
Zentalis Pharmaceuticals Return on equity
Direct answer
Zentalis Pharmaceuticals's return on equity is -66.75%.
The verified market snapshot reports -66.75%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 16, 2026.
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -66.75%
Explore related company data
View Zentalis Pharmaceuticals's market capitalizationView Zentalis Pharmaceuticals's price-to-book ratioView Zentalis Pharmaceuticals's 52-week price rangeView Zentalis Pharmaceuticals's profit marginView Zentalis Pharmaceuticals's debt-to-equity ratioView all Zentalis Pharmaceuticals key metricsReturn to Zentalis Pharmaceuticals profile